Amid falling vaccination rates, the US maintains global records for both total cases and deaths.
A woman adding flowers to a New York City memorial to those who died due to the virus
The US also ranks highest in total number of recorded cases, with nearly 33.5 million infections since 2020. It took around four months for the US to go from 500,000 to 600,000 deaths - about as long as it took to go from none to 100,000. It marks a significant change from the height of the pandemic when the death toll jumped from 300,000 to 400,000 in one month last winter.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
As US COVID-19 death toll nears 600,000, racial gaps persistJerry Ramos spent his final days in a California hospital, hooked to an oxygen machine with blood clots in his lungs from COVID-19, his 3-year-old daughter in his thoughts. Ramos didn't live to see it. The approaching 600,000 mark, as tracked by Johns Hopkins University, is greater than the population of Baltimore or Milwaukee.
Read more »
As US COVID-19 death toll nears 600,000, racial gaps persistThe U.S. death toll from COVID-19 is approaching 600,000, with the virus still taking advantage of inequalities across the country.
Read more »
U.S. has administered over 309 million doses of Covid-19 vaccines, CDC saysThe figures were up from the more than 308 million doses the CDC said had been administered as of Saturday, out of over 374 million that had been doses delivered.
Read more »
Novavax COVID-19 vaccine more than 90% effective in U.S. trialNovavax Inc (NVAX.O) on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus.
Read more »
Novavax says Covid-19 vaccine shows 90.4% overall efficacy in US/Mexico Phase 3 trialJUST IN: Novavax says its coronavirus vaccine has an overall efficacy of 90.4% and was 'generally well-tolerated' in a Phase 3 trial in the US and Mexico
Read more »